Loeb Partners Corp’s CVS Health CVS Stock Holding History

Loeb Partners Corp’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,000	Closed	–	–	153
2018 Q2	$0	Hold	10,000	–	–	﹤0.01%	163
2018 Q1	$622K	Hold	10,000	–	–	0.27%	78
2017 Q4	$725K	Buy	+10,000	New	+$727K	0.21%	90
2017 Q1	–	Sell	-10,100	Closed	-$797K	–	163
2016 Q4	$797K	Sell	10,100 -10,400	-51%	-$842K	0.27%	83
2016 Q3	$1.82M	Hold	20,500	–	–	0.65%	41
2016 Q2	$1.96M	Buy	20,500 +7,500	+58%	+$747K	0.65%	43
2016 Q1	$1.35M	Hold	13,000	–	–	0.48%	54
2015 Q4	$1.27M	Sell	13,000 -500	-4%	-$49K	0.41%	49
2015 Q3	$1.3M	Buy	13,500 +3,500	+35%	+$368K	0.48%	51
2015 Q2	$1.05M	Sell	10,000 -3,000	-23%	-$307K	0.3%	76
2015 Q1	$1.34M	Buy	13,000 +10,000	+333%	+$1.01M	0.39%	64
2014 Q4	$289K	Sell	3,000 -7,000	-70%	-$617K	0.09%	147
2014 Q3	$796K	Buy	+10,000	New	+$788K	0.26%	89
2014 Q2	–	Sell	-7,000	Closed	-$524K	–	187
2014 Q1	$524K	Hold	7,000	–	–	0.18%	112
2013 Q4	$501K	Buy	+7,000	New	+$450K	0.16%	123
2013 Q3	–	Sell	-5,000	Closed	-$286K	–	184
2013 Q2	$286K	Buy	+5,000	New	+$290K	0.1%	144

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loeb Partners Corp's CVS Position: Q3 2018 in Review

Loeb Partners Corp sold out of CVS Health (CVS) in Q3 2018, closing a stake of 10,000 shares.

Loeb Partners Corp first reported a position in CVS in Q2 2013 and held it in 16 quarters. The position peaked at $1.96M in Q2 2016. 1,599 funds tracked by Wall St. Rank hold CVS as of Q3 2018.

Loeb Partners Corp reported no remaining CVS Health position as of Q3 2018 after selling out during the quarter.
Loeb Partners Corp sold 10,000 CVS Health shares in Q3 2018.
Loeb Partners Corp first reported a position in CVS Health in Q2 2013 and held it in 16 quarters.
Loeb Partners Corp's CVS Health position peaked at $1.96M in Q2 2016.
1,599 funds tracked by Wall St. Rank held CVS Health as of Q3 2018.

Based on Loeb Partners Corp's 13F filing for Q3 2018, filed 9 Nov 2018.